BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37873162)

  • 1. Histone H3 E50K mutation confers oncogenic activity and supports an EMT phenotype.
    Sad K; Jones CY; Adams M; Lustenberger S; Lee RS; Elayavalli SR; Farhi J; Lemon LD; Fasken MB; Corbett AH; Spangle JM
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations.
    Lemon LD; Kannan S; Mo KW; Adams M; Choi HG; Gulka AOD; Withers ES; Nurelegne HT; Gomez V; Ambrocio RE; Tumminkatti R; Lee RS; Wan M; Fasken MB; Spangle JM; Corbett AH
    G3 (Bethesda); 2022 Jul; 12(7):. PubMed ID: 35567477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
    Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?
    Chan KM; Han J; Fang D; Gan H; Zhang Z
    Cell Cycle; 2013 Aug; 12(16):2546-52. PubMed ID: 23907119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains.
    Iwasaki W; Tachiwana H; Kawaguchi K; Shibata T; Kagawa W; Kurumizaka H
    Biochemistry; 2011 Sep; 50(36):7822-32. PubMed ID: 21812398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sin mutations of histone H3: influence on nucleosome core structure and function.
    Kurumizaka H; Wolffe AP
    Mol Cell Biol; 1997 Dec; 17(12):6953-69. PubMed ID: 9372928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding landscape of 'oncohistone' mutations in human cancers.
    Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
    Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
    Bennett RL; Bele A; Small EC; Will CM; Nabet B; Oyer JA; Huang X; Ghosh RP; Grzybowski AT; Yu T; Zhang Q; Riva A; Lele TP; Schatz GC; Kelleher NL; Ruthenburg AJ; Liphardt J; Licht JD
    Cancer Discov; 2019 Oct; 9(10):1438-1451. PubMed ID: 31337617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3K27M Mutation in Brain Tumors.
    El-Hashash AHK
    Adv Exp Med Biol; 2021; 1283():43-52. PubMed ID: 33155136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells.
    Peláez IM; Kalogeropoulou M; Ferraro A; Voulgari A; Pankotai T; Boros I; Pintzas A
    Int J Biochem Cell Biol; 2010 Jun; 42(6):911-20. PubMed ID: 20109579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone H3-H4 chaperone pathways rescues C. elegans sterility by H2B loss.
    Zhao R; Zhu Z; Geng R; Jiang X; Li W; Ou G
    PLoS Genet; 2022 Jun; 18(6):e1010223. PubMed ID: 35679337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.
    Shastrula PK; Lund PJ; Garcia BA; Janicki SM
    J Biol Chem; 2018 Aug; 293(32):12360-12377. PubMed ID: 29921582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Mechanisms of Histone H3 Mutations.
    Weinberg DN; Allis CD; Lu C
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27864305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3 lysine 36 methylation antagonizes silencing in Saccharomyces cerevisiae independently of the Rpd3S histone deacetylase complex.
    Tompa R; Madhani HD
    Genetics; 2007 Feb; 175(2):585-93. PubMed ID: 17179083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Molecular Underpinnings of Cancer-Causing Oncohistone Mutants Using Yeast as a Model.
    Zhang X; Fawwal DV; Spangle JM; Corbett AH; Jones CY
    J Fungi (Basel); 2023 Dec; 9(12):. PubMed ID: 38132788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Previously uncharacterized amino acid residues in histone H3 and H4 mutants with roles in DNA damage repair response and cellular aging.
    Thakre PK; Sv A; Golla U; Chauhan S; Tomar RS
    FEBS J; 2019 Mar; 286(6):1154-1173. PubMed ID: 30536627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of histone H3 and H4 residues to heterochromatin structure.
    Yu Q; Olsen L; Zhang X; Boeke JD; Bi X
    Genetics; 2011 Jun; 188(2):291-308. PubMed ID: 21441216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals.
    Trovato M; Patil V; Gehre M; Noh KM
    Cells; 2020 Dec; 9(12):. PubMed ID: 33353064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone H2B Mutations in Cancer.
    Wan YCE; Chan KM
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34205231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ddc1-Mec3-Rad17 sliding clamp regulates histone-histone chaperone interactions and DNA replication-coupled nucleosome assembly in budding yeast.
    Burgess RJ; Han J; Zhang Z
    J Biol Chem; 2014 Apr; 289(15):10518-10529. PubMed ID: 24573675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.